Clinical and angiographic risk assessment in patients with left main stem lesions

JACC: Cardiovascular Interventions

Volumn 3, Issue 9, 2010, Pages 891-901

  Garg, Scot ^a   Stone, Gregg W ^b   Kappetein, Arie Peter ^a   Sabik III, Joseph F ^c   Simonton, Charles ^d   Serruys, Patrick W ^a  

^a ERASMUS MEDICAL CENTER   (Netherlands)

^b NewYork Presbyterian Hospital   (United States)

^c LERNER RESEARCH INSTITUTE   (United States)

^d ABBOTT VASCULAR   (United States)

Author keywords

ACEF score; clinical SYNTAX score; coronary artery bypass grafting; EuroSCORE; global risk classification; percutaneous coronary intervention; stenting; SYNTAX score; unprotected left main stem

Indexed keywords

ADULT; AGED; ANGIOCARDIOGRAPHY; FEMALE; HEART INJURY; HUMAN; LEFT MAIN STEM LESION; MALE; PERCUTANEOUS CORONARY INTERVENTION; PRIORITY JOURNAL; REVASCULARIZATION; REVIEW; RISK ASSESSMENT;

CORONARY ANGIOGRAPHY; CORONARY STENOSIS; HUMANS; MYOCARDIAL REVASCULARIZATION; RISK ASSESSMENT;

EID: 77956636005     PISSN: 19368798     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jcin.2010.06.016     Document Type: Review

References (56)

1. D.P. Taggart, S. Kaul, and W.E. Boden Revascularization for unprotected left main stem coronary artery stenosis stenting or surgery J Am Coll Cardiol 51 2008 885 892
2. D. Taggart The DELFT (Drug Eluting stent for LeFT main) Registry: the unknowns J Am Coll Cardiol 52 2008 1680 1681
3. E. Meliga, A.O. Maree, H.M. Garcia-Garcia, and P.W. Serruys Reply J Am Coll Cardiol 52 2008 1681
4. S. Yusuf, D. Zucker, and P. Peduzzi Effect of coronary artery bypass graft surgery on survival: overview of 10-year results from randomised trials by the Coronary Artery Bypass Graft Surgery Trialists Collaboration Lancet 344 1994 563 570
5. P.W. Serruys, F. Unger, J.E. Sousa Arterial Revascularization Therapies Study Group Comparison of coronary-artery bypass surgery and stenting for the treatment of multivessel disease N Engl J Med 344 2001 1117 1124 (Pubitemid 32285232)
6. P.W. Serruys, Y. Onuma, S. Garg ARTS II Investigators 5-year clinical outcomes of the ARTS II (Arterial Revascularization Therapies Study II) of the sirolimus-eluting stent in the treatment of patients with multivessel de novo coronary artery lesions J Am Coll Cardiol 55 2010 1093 1101
7. A.P. Kappetein, K.D. Dawkins, and F.W. Mohr Current percutaneous coronary intervention and coronary artery bypass grafting practices for three-vessel and left main coronary artery disease Insights from the SYNTAX run-in phase Eur J Cardiothorac Surg 29 2006 486 491
8. D.E. Kandzari, A. Colombo, S.J. Park American College of Cardiology Interventional Scientific Council Revascularization for unprotected left main disease: evolution of the evidence basis to redefine treatment standards J Am Coll Cardiol 54 2009 1576 1588
9. P.W. Serruys, M.C. Morice, A.P. Kappetein SYNTAX Investigators Percutaneous coronary intervention versus coronary-artery bypass grafting for severe coronary artery disease N Engl J Med 360 2009 961 972
10. Kappetein AP. Optimal revascularization strategy in patients with three-vessel disease and/or left main disease. The 2-year outcomes of the SYNTAX Trial. Paper presented at: ESC Congress; September 2, 2009; Barcelona.
11. F.G. Kushner, M. Hand, and S.C. Smith Jr. 2009 focused updates: ACC/AHA guidelines for the management of patients with ST-elevation myocardial infarction (updating the 2004 guideline and 2007 focused update) and ACC/AHA/SCAI guidelines on percutaneous coronary intervention (updating the 2005 guideline and 2007 focused update): a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines J Am Coll Cardiol 54 2009 2205 2241
12. M. Lindstaedt, M. Spiecker, and C. Perings How good are experienced interventional cardiologists at predicting the functional significance of intermediate or equivocal left main coronary artery stenoses? Int J Cardiol 120 2007 254 261
13. L.D. Fisher, M.P. Judkins, and J. Lesperance Reproducibility of coronary arteriographic reading in the coronary artery surgery study (CASS) Cathet Cardiovasc Diagn 8 1982 565 575
14. M. Hamilos, O. Muller, and T. Cuisset Long-term clinical outcome after fractional flow reserve-guided treatment in patients with angiographically equivocal left main coronary artery stenosis Circulation 120 2009 1505 1512
15. C.J. Botman, J. Schonberger, and S. Koolen Does stenosis severity of native vessels influence bypass graft patency? A prospective fractional flow reserve-guided study Ann Thorac Surg 83 2007 2093 2097
16. A.S. Abizaid, G.S. Mintz, and A. Abizaid One-year follow-up after intravascular ultrasound assessment of moderate left main coronary artery disease in patients with ambiguous angiograms J Am Coll Cardiol 34 1999 707 715
17. P. Vranckx, E. Meliga, P.P. De Jaegere, M. Van den Ent, E.S. Regar, and P.W. Serruys The TandemHeart, percutaneous transseptal left ventricular assist device: a safeguard in high-risk percutaneous coronary interventions The six-year Rotterdam experience EuroIntervention 4 2008 331 337
18. K.J. Jorgensen, J. Brodersen, O.J. Hartling, M. Nielsen, and P.C. Gotzsche Informed choice requires information about both benefits and harms J Med Ethics 35 2009 268 269
19. S.A. Nashef, F. Roques, P. Michel, E. Gauducheau, S. Lemeshow, and R. Salamon European system for cardiac operative risk evaluation (EuroSCORE) Eur J Cardiothorac Surg 16 1999 9 13
20. I.K. Toumpoulis, C.E. Anagnostopoulos, J.J. DeRose, and D.G. Swistel European system for cardiac operative risk evaluation predicts long-term survival in patients with coronary artery bypass grafting Eur J Cardiothorac Surg 25 2004 51 58
21. I.K. Toumpoulis, C.E. Anagnostopoulos, D.G. Swistel, and J.J. DeRose Jr Does EuroSCORE predict length of stay and specific postoperative complications after cardiac surgery? Eur J Cardiothorac Surg 27 2005 128 133
22. R. De Maria, M. Mazzoni, and M. Parolini Predictive value of EuroSCORE on long term outcome in cardiac surgery patients: a single institution study Heart 91 2005 779 784
23. F. Roques, S.A. Nashef, and P. Michel Risk factors and outcome in European cardiac surgery: analysis of the EuroSCORE multinational database of 19030 patients Eur J Cardiothorac Surg 15 1999 816 822 discussion 8223
24. M.C. Morice, P.W. Serruys, and A.P. Kappetein Outcomes in patients with de novo left main disease treated with either percutaneous coronary intervention using TAXUS Express2 paclitaxel-eluting stent or coronary artery bypass graft treatment in the SYNTAX Trial Circulation 121 2010 2645 2653
25. J. Rods-Cabau, J. Deblois, and O.F. Bertrand Nonrandomized comparison of coronary artery bypass surgery and percutaneous coronary intervention for the treatment of unprotected left main coronary artery disease in octogenarians Circulation 118 2008 2374 2381
26. Y.H. Kim, D.W. Park, and W.J. Kim Validation of SYNTAX (Synergy between PCI with Taxus and Cardiac Surgery) score for prediction of outcomes after unprotected left main coronary revascularization J Am Coll Cardiol Intv 3 2010 612 623
27. Y.H. Kim, J.M. Ahn, and D.W. Park EuroSCORE as a predictor of death and myocardial infarction after unprotected left main coronary stenting Am J Cardiol 98 2006 1567 1570
28. E. Romagnoli, F. Burzotta, and C. Trani EuroSCORE as predictor of in-hospital mortality after percutaneous coronary intervention Heart 95 2009 43 48
29. F. Roques, P. Michel, A.R. Goldstone, and S.A. Nashef The logistic EuroSCORE Eur Heart J 24 2003 881 882
30. M. Singh, C.S. Rihal, R.J. Lennon, J. Spertus, J.S. Rumsfeld, and D.R. Holmes Bedside estimation of risk from percutaneous coronary intervention: the new Mayo Clinic Risk Scores Mayo Clin Proc 82 2007 701 708
31. M. Singh, B.J. Gersh, and S. Li Mayo Clinic Risk Score for percutaneous coronary intervention predicts in-hospital mortality in patients undergoing coronary artery bypass graft surgery Circulation 117 2008 356 362
32. M. Singh, C.S. Rihal, R.J. Lennon, K.N. Garratt, and D.R. Holmes Jr Comparison of Mayo Clinic Risk Score and American College of Cardiology/American Heart Association lesion classification in the prediction of adverse cardiovascular outcome following percutaneous coronary interventions J Am Coll Cardiol 44 2004 357 361
33. M. Ranucci, S. Castelvecchio, L. Menicanti, A. Frigiola, and G. Pelissero Risk of assessing mortality risk in elective cardiac operations: age, creatinine, ejection fraction, and the law of parsimony Circulation 119 2009 3053 3061
34. P.W. Serruys, Y. Onuma, and S. Garg Assessment of the SYNTAX score in the Syntax study EuroIntervention 5 2009 50 56
35. S. Garg, C. Girasis, G. Sarno SYNTAX Trial Investigators The SYNTAX score revisited: a reassessment of the SYNTAX score reproducibility Catheter Cardiovasc Interv 75 2010 946 952
36. T.J. Ryan, W.B. Bauman, and J.W. Kennedy Guidelines for percutaneous transluminal coronary angioplasty A report of the American Heart Association/American College of Cardiology Task Force on Assessment of Diagnostic and Therapeutic Cardiovascular Procedures (Committee on Percutaneous Transluminal Coronary Angioplasty) Circulation 88 1993 2987 3007
37. A. Kastrati, A. Schomig, and S. Elezi Prognostic value of the modified American college of Cardiology/American Heart Association stenosis morphology classification for long-term angiographic and clinical outcome after coronary stent placement Circulation 100 1999 1285 1290
38. A.A. Khattab, C.W. Hamm, J. Senges German Cypher Registry Prognostic value of the modified American College of Cardiology/American Heart Association lesion morphology classification for clinical outcome after sirolimus-eluting stent placement (results of the prospective multicenter German Cypher Registry) Am J Cardiol 101 2008 477 482
39. M. Valgimigli, P.W. Serruys, K. Tsuchida ARTS II Cyphering the complexity of coronary artery disease using the syntax score to predict clinical outcome in patients with three-vessel lumen obstruction undergoing percutaneous coronary intervention Am J Cardiol 99 2007 1072 1081
40. D. Capodanno, M.E. Di Salvo, G. Cincotta, M. Miano, C. Tamburino, and C. Tamburino Usefulness of the SYNTAX Score for Predicting Clinical Outcome After Percutaneous Coronary Intervention of Unprotected Left Main Coronary Artery Disease Circ Cardiovasc Interv 2 2009 302 308
41. G. Sianos, M.A. Morel, and A.P. Kappetein The SYNTAX Score: an angiographic tool grading the complexity of coronary artery disease EuroIntervention 1 2005 219 227
42. SYNTAX Score www.syntaxscore.com Accessed March 1, 2010
43. D. Capodanno, P. Capranzano, and M.E. Di Salvo Usefulness of SYNTAX score to select patients with left main coronary artery disease to be treated with coronary artery bypass graft J Am Coll Cardiol Intv 2 2009 731 738
44. Y. Onuma, C. Girasis, and N. Piazza Long-term clinical results following stenting of the left main steminsights from RESEARCH and T-SEARCH Registries J Am Coll Cardiol Intv 3 2010 584 594
45. J. Wykrzykowska, S. Garg, and C. Girasis Value of the Syntax Score (SX) for risk assessment in the "all-comers" population of the randomized multicenter LEADERS (Limus Eluted from A Durable versus ERodable Stent coating) trial J Am Coll Cardiol 56 2010 272 277
46. Girasis C, Garg S, Raber L, et al. Prediction of 5-year clinical outcomes using the SYNTAX score in patients undergoing PCI from the Sirolimus Eluting Stent Compared With Paclitaxel Eluting Stent for Coronary Revascularisation (SIRTAX) trial. Abstract presented at: American College of Cardiology meeting; March 1416, 2010; Atlanta, GA.
47. Serruys PW. Left main lessons from SYNTAX (early results and 2 year follow-up): interventional perspectives. Paper presented at: Transcatheter Cardiovascular Therapeutics; September 21, 2009; San Francisco, CA. Available at: www.tctmd.com/txshow.aspx?tid=9390768&id=83938&trid=938634. Accessed March 1, 2010.
48. O. Birim, M. van Gameren, A.J. Bogers, P.W. Serruys, F.W. Mohr, and A.P. Kappetein Complexity of coronary vasculature predicts outcome of surgery for left main disease Ann Thorac Surg 87 2009 1097 1104 discussion 11045
49. A.L. Shroyer, L.P. Coombs, E.D. Peterson The Society of Thoracic Surgeons The Society of Thoracic Surgeons: 30-day operative mortality and morbidity risk models Ann Thorac Surg 75 2003 1856 1864 discussion 18645
50. D.M. Shahian, S.M. O'Brien, G. Filardo Society of Thoracic Surgeons Quality Measurement Task Force The Society of Thoracic Surgeons 2008 cardiac surgery risk models: part 1coronary artery bypass grafting surgery Ann Thorac Surg 88 2009 S2 S22
51. N. Ad, S.D. Barnett, and A.M. Speir The performance of the EuroSCORE and the Society of Thoracic Surgeons mortality risk score: the gender factor Interact Cardiovasc Thorac Surg 6 2007 192 195
52. S. Garg, G. Sarno, H.M. Garcia-Garcia ARTS-II Investigators A new tool for the risk stratification of patients with complex coronary artery disease: the Clinical SYNTAX Score Circ Cardiovasc Interv 3 2010 317 326
53. J. Walter, A. Mortasawi, and B. Arnrich Creatinine clearance versus serum creatinine as a risk factor in cardiac surgery BMC Surg 3 2003 4
54. D. Capodanno, M. Miano, and G. Cincotta EuroSCORE refines the predictive ability of SYNTAX score in patients undergoing left main percutaneous coronary intervention Am Heart J 159 2010 103 109
55. J. Concato, A.R. Feinstein, and T.R. Holford The risk of determining risk with multivariable models Ann Intern Med 118 1993 201 210
56. S.L. Chen, J.P. Chen, and G. Mintz Comparison between the NERS (New Risk Stratification) score and the SYNTAX (Synergy between Percutaneous Coronary Intervention with Taxus and Cardiac Surgery) score in outcome prediction for unprotected left main stenting J Am Coll Cardiol Intv 3 2010 632 641